|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu L, Yang S, He S, Qiang F, Cai J, Liu
R, Gu C, Guo Z, Wang C, Zhang W, et al: Downregulation of
ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell
proliferation and metastasis, but promotes apoptosis. J Mol Histol.
47:69–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dasso M: The Ran GTPase: Theme and
variations. Curr Biol. 12:R502–R508. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sazer S and Dasso M: The ran decathlon:
Multiple roles of Ran. J Cell Sci. 113:1111–1118. 2000.PubMed/NCBI
|
|
5
|
Chafe SC, Pierce JB and Mangroo D:
Nuclear-cytoplasmic trafficking of NTF2, the nuclear import
receptor for the RanGTPase, is subjected to regulation. PLoS One.
7:e425012012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hetzer M, Bilbao-Cortés D, Walther TC,
Gruss OJ and Mattaj IW: GTP hydrolysis by Ran is required for
nuclear envelope assembly. Mol Cell. 5:1013–1024. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lonhienne TG, Forwood JK, Marfori M, Robin
G, Kobe B and Carroll BJ: Importin-beta is a GDP-to-GTP exchange
factor of Ran: Implications for the mechanism of nuclear import. J
Biol Chem. 284:22549–22558. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cimica V, Chen HC, Iyer JK and Reich NC:
Dynamics of the STAT3 transcription factor: Nuclear import
dependent on Ran and importin-β1. PLoS One. 6:e201882011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Doherty KJ, McKay C, Chan KK and El-Tanani
MK: Ran GTPase as a target for cancer therapy: Ran binding
proteins. Curr Mol Med. 11:686–695. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Segev N: Coordination of intracellular
transport steps by GTPases. Semin Cell Dev Biol. 22:33–38. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cook AG and Conti E: Nuclear export
complexes in the frame. Curr Opin Struct Biol. 20:247–252. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saxena S, Gandhi A, Lim PW, Relles D,
Sarosiek K, Kang C, Chipitsyna G, Sendecki J, Yeo CJ and Arafat HA:
Ran GTPase and osteopontin in pancreatic cancer. Pancreat Disord
Ther. 3:1132013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia F, Lee CW and Altieri DC: Tumor cell
dependence on Ran-GTP-directed mitosis. Cancer Res. 68:1826–1833.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morgan-Lappe SE, Tucker LA, Huang X, Zhang
Q, Sarthy AV, Zakula D, Vernetti L, Schurdak M, Wang J and Fesik
SW: Identification of Ras-related nuclear protein, targeting
protein for xenopus kinesin-like protein 2, and stearoyl-CoA
desaturase 1 as promising cancer targets from an RNAi-based screen.
Cancer Res. 67:4390–4398. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kurisetty VV, Johnston PG, Johnston N,
Erwin P, Crowe P, Fernig DG, Campbell FC, Anderson IP, Rudland PS
and El-Tanani MK: Ran GTPase is an effector of the
invasive/metastatic phenotype induced by osteopontin. Oncogene.
27:7139–7149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Muniyappa MK, Dowling P, Henry M, Meleady
P, Doolan P, Gammell P, Clynes M and Barron N: MiRNA-29a regulates
the expression of numerous proteins and reduces the invasiveness
and proliferation of human carcinoma cell lines. Eur J Cancer.
45:3104–3118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ly TK, Wang J, Pereira R, Rojas KS, Peng
X, Feng Q, Cerione RA and Wilson KF: Activation of the Ran GTPase
is subject to growth factor regulation and can give rise to
cellular transformation. J Biol Chem. 285:5815–5826. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ouellet V, Guyot MC, Le Page C,
Filali-Mouhim A, Lussier C, Tonin PN, Provencher DM and Mes-Masson
AM: Tissue array analysis of expression microarray candidates
identifies markers associated with tumor grade and outcome in
serous epithelial ovarian cancer. Int J Cancer. 119:599–607. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abe H, Kamai T, Shirataki H, Oyama T, Arai
K and Yoshida K: High expression of Ran GTPase is associated with
local invasion and metastasis of human clear cell renal cell
carcinoma. Int J Cancer. 122:2391–2397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsai MY, Wiese C, Cao K, Martin O, Donovan
P, Ruderman J, Prigent C and Zheng Y: A Ran signalling pathway
mediated by the mitotic kinase Aurora A in spindle assembly. Nat
Cell Biol. 5:242–248. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Silljé HH, Nagel S, Körner R and Nigg EA:
HURP is a Ran-importin beta-regulated protein that stabilizes
kinetochore microtubules in the vicinity of chromosomes. Curr Biol.
16:731–742. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Joukov V, Groen AC, Prokhorova T, Gerson
R, White E, Rodriguez A, Walter JC and Livingston DM: The
BRCA1/BARD1 heterodimer modulates Ran-dependent mitotic spindle
assembly. Cell. 127:539–552. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuen HF, Chan KK, Grills C, Murray JT,
Platt-Higgins A, Eldin OS, O'Byrne K, Janne P, Fennell DA, Johnston
PG, et al: Ran is a potential therapeutic target for cancer cells
with molecular changes associated with activation of the
PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways. Clin Cancer Res.
18:380–391. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ning J, Liu W, Zhang J, Lang Y and Xu S:
Ran GTPase induces EMT and enhances invasion in non-small cell lung
cancer cells through activation of PI3K-AKT pathway. Oncol Res.
21:67–72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Runowicz CD, Leach CR, Henry NL, Henry KS,
Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge
SB, Jacobs LA, et al: American Cancer Society/American Society of
clinical oncology breast cancer survivorship care guideline. CA
Cancer J Clin. 66:43–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Meeran SM, Patel SN, Chen H, Hardy
TM and Tollefsbol TO: Epigenetic reactivation of estrogen
receptor-α (ERα) by genistein enhances hormonal therapy sensitivity
in ERα-negative breast cancer. Mol Cancer. 12:92013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Görlich D, Kostka S, Kraft R, Dingwall C,
Laskey RA, Hartmann E and Prehn S: Two different subunits of
importin cooperate to recognize nuclear localization signals and
bind them to the nuclear envelope. Curr Biol. 5:383–392. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barrès V, Ouellet V, Lafontaine J, Tonin
PN, Provencher DM and Mes-Masson AM: An essential role for Ran
GTPase in epithelial ovarian cancer cell survival. Mol Cancer.
9:2722010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deng L, Lu Y, Zhao X, Sun Y, Shi Y, Fan H,
Liu C, Zhou J, Nie Y, Wu K, et al: Ran GTPase protein promotes
human pancreatic cancer proliferation by deregulating the
expression of Survivin and cell cycle proteins. Biochem Biophys Res
Commun. 440:322–329. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deng L, Shang Y, Guo S, Liu C, Zhou L, Sun
Y, Nie Y, Fan D, Lu Y and Guo X: Ran GTPase protein promotes
metastasis and invasion in pancreatic cancer by deregulating the
expression of AR and CXCR4. Cancer Biol Ther. 15:1087–1093. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dallol A, Hesson LB, Matallanas D, Cooper
WN, O'Neill E, Maher ER, Kolch W and Latif F: RAN GTPase is a
RASSF1A effector involved in controlling microtubule organization.
Curr Biol. 19:1227–1232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jeon H, Zheng LT, Lee S, Lee WH, Park N,
Park JY, Heo WD, Lee MS and Suk K: Comparative analysis of the role
of small G proteins in cell migration and cell death:
Cytoprotective and promigratory effects of RalA. Exp Cell Res.
317:2007–2018. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yuen HF, Chan KK, Grills C, Murray JT,
Platt-Higgins A, Eldin OS, O'Byrne K, Janne P, Fennell DA, Johnston
PG, et al: Ran is a potential therapeutic target for cancer cells
with molecular changes associated with activation of the
PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways. Clin Cancer Res.
18:380–391. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Foroni C, Broggini M, Generali D and Damia
G: Epithelial mesenchymal transition and breast cancer: Role,
molecular mechanisms and clinical impact. Cancer Treat Rev.
38:689–697. 2012. View Article : Google Scholar : PubMed/NCBI
|
